tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

PHAR

0

Getting the most from clinical experts in the time of COVID-19: Lessons learned

Posted on April 5, 2021 by Michael Broder

Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading →

COVID-19, PHAR covid-19, PHAR
0

The 5 Numbers That Will Define Healthcare Value in 2021

Posted on January 11, 2021 by Michael Broder

19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading →

Guest Bloggers, PHAR ACA, affordable care act, coronavirus, covid-19, health care value, ICER, Michael Broder, PHAR, vaccines
0

How Health Economics and Outcomes Researchers Can Help Defeat COVID-19

Posted on October 6, 2020 by Michael Broder

As of October 2, 2020, the novel coronavirus has infected more than 34 million people, including President Donald J. Trump and First Lady Melania Trump, and killed over one million, resulting in a global economic decline on a scale not… Continue Reading →

COVID-19, Guest Bloggers, PHAR coronavirus, covid-19, Michael Broder, PHAR

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • The Emerging Outcomes Demonstration / Cost Management Challenge
  • Hard to Define, Harder to Find Patients: Using AI & Real-World Data to Understand Treatment Resistant Depression
  • Get to Know R-S-S (Regulatory Scientific and Health Solutions)
  • Will 2023 Be the Year AI Disrupts Healthcare?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
24 Mar

AMCP 2023 Panel Argues for Patient-Centered Prior Authorization

http://ow.ly/RZ4050NrAhI

#HEOR #Payers #PatientCentered #Healthcare

Reply on Twitter 1639379097456607233 Retweet on Twitter 1639379097456607233 Like on Twitter 1639379097456607233 1 Twitter 1639379097456607233
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
24 Mar

NICE Recommends Novel Gene Therapy for Rare Genetic Brain Disorder

http://ow.ly/1wIc50NrzLB

#HEOR #RareDisease #OrphanDrug #Therapeutics #GeneTherapy

Reply on Twitter 1639364008468951040 Retweet on Twitter 1639364008468951040 Like on Twitter 1639364008468951040 Twitter 1639364008468951040
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
24 Mar

Patient Advocacy Groups Decry NIH Refusing to Exert March-In Rights for Prostate Cancer Drug Xtandi

http://ow.ly/mWTS50Nry5X

#HEOR #DrugPrices #Patents #Therapeutics #Pharma

Reply on Twitter 1639348911264636929 Retweet on Twitter 1639348911264636929 Like on Twitter 1639348911264636929 Twitter 1639348911264636929
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes